Skip to main content

Moderna to begin clinical trials of Covid booster shots for variant from South Africa, sends to NIH for study

Moderna said it has shipped to the NIH doses of a new Covid-19 vaccine designed to provide better protection against the South Africa variant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.